School of Medicine
Showing 5,941-5,960 of 12,920 Results
-
Uri Ladabaum
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsGastrointestinal cancer prevention and risk management. Risk stratification. Cost-effectiveness analysis. Health services research.
-
Amy Ladd, MD
Elsbach-Richards Professor of Surgery, Emerita
Current Research and Scholarly InterestsResearch Interests
1. The kinematics and forces associated with thumb carpometcarpal (CMC) function and pathology
2. The anatomy, microstructure, and immunofluorescent characteristics of the thumb CMC joint
3. Pathomechaniics of CMC arthritis: biomechanical wear, injury, genetic, and environmental causes
4. Biomechanics of the golf swing
5. Archiving, vitalizing, and innovating medical and surgical knowledge, most recently with innovative iBook monographs -
Magdalena Ladrón de Guevara
Postdoctoral Scholar, Reproductive Biology
BioMagdalena Ladrón de Guevara is a postdoctoral scholar in reproductive biology whose research investigates the molecular and cellular mechanisms driving early human embryo implantation and trophoblast behavior. Her work integrates single-cell and spatial transcriptomics, live imaging, CRISPR-based functional genomics, and genome editing to explore embryo–maternal interactions within the implantation niche.
Originally trained as a veterinarian in Argentina, Magdalena earned a master’s in Animal Genetics and Reproductive Biotechnology in Spain and completed her Ph.D. in Reproductive and Developmental Biology at the Università degli Studi di Milano as part of the Marie Skłodowska-Curie EUROVA network. Her experience spans both veterinary and human assisted reproduction, with deep expertise in embryo culture, oocyte maturation, gene regulation, genome editing, and the generation of genetically engineered mouse models. She brings a translational perspective to developmental biology and fertility research. -
Richard Lafayette
Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsWe are continuing to grow a glomerulonephritis cohort study, including immunologic characterization. We have completed interventional studies of preeclampsia exploring the nitric oxide, endothelin system and effects on glomerular function and morphometry. We continue to recruit patients for treatment and observational studies of glomerular disease, including FSGS, membranous and particularly IgA nephropathy. We also are actively studying renal disease in systemic amyloidosis.
-
Teresa LaFromboise
Professor of Education
Current Research and Scholarly InterestsBicultural competence and resilience in ethnic minority adolescent development. Particularly, the influence of enculturation and acculturation experiences on adolescent development. Cultural considerations in individual, school and community-based psychological interventions with adolescents and emerging adults.
-
Aimmon Lago
Affiliate, Biomedical Informatics (BMI) graduate training program
BioAimmon is a healthcare and technology leader with over 20 years of experience supporting teams at Accenture, Kaiser Permanente, and Stanford Health Care. He currently serves as the Executive IT Director of Revenue Cycle and Population Health Systems at Stanford Health Care where he helps create and sustain financial value, employee engagement, and patient experience improvement.
Aimmon holds a MS in Clinical Informatics Management from Stanford, a MS in Healthcare Administration from California State University East Bay, and a BS in Business Administration from Santa Clara University.
He is excited about the opportunities for cost, quality, and access improvement in healthcare, and seeks to create meaningful and sustained change with the use of technology, organizational management, and financial tools. -
Mauro Lago Docampo
Postdoctoral Scholar, Cardiology
Current Research and Scholarly InterestsI have always been fascinated by the process of genetic penetrance, how two people can carry the same mutation but only one of them may be affected.
My main project focuses on understanding the role of TBX4 in the development of Pulmonary Arterial Hypertension (PAH). Mutations in this gene are related to very different diseases. In my research, I mix cellular models, gene editing, and high throughput assays to find the determinants of penetrance in the development of PAH under these conditions. -
Sheila Lahijani, MD, FACLP
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Lahijani is a Clinical Professor of Medical Psychiatry at Stanford University School of Medicine and a nationally recognized leader in psycho-oncology. With extensive training and expertise in internal medicine, psychiatry, and consultation-liaison psychiatry, she has made significant contributions to the integration of psychiatric care within oncological settings.
Since her appointment at Stanford in 2015, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center, where she provides medical psychiatric consultation services and collaborates with interdisciplinary teams to enhance patient outcomes. In her capacity as Medical Director of the Stanford Cancer Center Psychosocial Oncology Program, a position she has held since 2019, she is responsible for the strategic development and implementation of comprehensive psychiatric services tailored to the unique needs of patients with cancer.
Additionally, Dr. Lahijani serves as the Section Chief of Psycho-Oncology in the Division of Medical Psychiatry where she oversees psych-onc faculty development and leads the training of medical psychiatry fellows in psycho-oncology. She also supervises advanced practice providers while also working as an attending psychiatric oncologist to provide care for patients with complex medical and psychiatric comorbidities across all hematology and oncology units.
Dr. Lahijani's academic credentials include her graduation from Brown Medical School, followed by the completion of a combined residency in Internal Medicine and Psychiatry at Rush University Medical Center. After completing residency, she practiced internal medicine and psychiatry with a focus on triple diagnosis (HIV, addiction medicine, mental health). She then further advanced through a Psychosomatic Medicine Fellowship at Northwestern University's Feinberg School of Medicine, during which time she received specialized training in psychiatric oncology at the Lurie Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.
Her clinical expertise encompasses psychopharmacology and a range of treatment modalities, including Meaning Centered Psychotherapy and Dignity Therapy. Dr. Lahijani is deeply committed to fostering relationship-centered skills and promoting provider wellness. As a faculty member of Advancing Communication Excellence at Stanford, she has led workshops designed to enhance communication competencies among faculty and staff.
Dr. Lahijani's scholarly pursuits are at the intersection of medicine and psychiatry, with a particular emphasis on the neuropsychiatric sequelae of cancer treatment, innovations in care, and medical education. She is dedicated to the education and mentorship of trainees in Psychiatry, Internal Medicine, Hematology/Oncology, and Neurology. Through her commitment to academic excellence, Dr. Lahijani plays a pivotal role in preparing the next generation of healthcare providers to adeptly navigate the intricate and multifaceted needs of patients and their caregivers, thereby promoting a comprehensive approach to patient care.
